Hematology and OncologyTrinity Health IHA medical groupYpsilanti, Michigan, United States
Disclosure information not submitted.
eP816 - A randomized phase-II trial testing triplet versus doublet chemotherapy to achieve complete response in patients with locally advanced rectal cancer
Monday, June 3, 202411:00 AM – 11:05 AM ET, USA